Steven Cohen Guardant Health, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,426,450 shares of GH stock, worth $38.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,426,450
Previous 70,000
1937.79%
Holding current value
$38.7 Million
Previous $1.89 Million
1454.52%
% of portfolio
0.07%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding GH
# of Institutions
309Shares Held
110MCall Options Held
2.51MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA11.4MShares$310 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$298 Million0.01% of portfolio
-
Baillie Gifford & CO6.23MShares$169 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$163 Million4.09% of portfolio
-
Cadian Capital Management, LP New York, NY5.79MShares$157 Million4.28% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.77B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...